C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.270
+0.060 (2.71%)
At close: Oct 3, 2025, 4:00 PM EDT
2.280
+0.010 (0.43%)
After-hours: Oct 3, 2025, 7:37 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $161.56 million as of October 3, 2025. Its market cap has decreased by -63.48% in one year.
Market Cap
161.56M
Enterprise Value
1.51M
1-Year Change
-63.48%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $161.56M, a decrease of -79.09%. That is a compound annual growth rate of -26.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 161.56M | -36.42% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |